MapLight Therapeutics, Inc. (MPLT)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$13.77+4.79%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MPLT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|---|
| Operating Expenses & Income | ||||
| R&D Expenses | 198.8 | 138.3 | 68.5 | — |
| Operating Income | (242.9) | (169.1) | (82.9) | — |
| Earnings from Continuing Operations | ||||
| Interest & Investment Income | 8.8 | 5.5 | 4.5 | — |
| Other Non-Operating Income / Expenses | — | 7.9 | 5.4 | — |
| Net Income | ||||
| Net Income | (229.8) | (161.2) | (77.6) | — |
| Per Share | ||||
| Basic EPS | (5.06) | (18.56) | (105.38) | — |
| Diluted EPS | (5.06) | (18.56) | (105.38) | — |
| Basic Weighted Avg Shares | 45.4 | 8.7 | 0.7 | — |
| Diluted Weighted Avg Shares | 45.4 | 8.7 | 0.7 | — |
| Supplemental | ||||
| EBIT | (242.9) | (169.1) | (82.9) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.